AstraZeneca CEO doubles down on U.S. amid rumors of listing shift
- Posted on July 29, 2025
- By CNBC
- 2 Views
AstraZeneca CEO doubles down on U.S. amid rumors of listing shift
AstraZeneca CEO Pascal Soriot said the U.K.-listed company had many reasons to be in the U.S., adding that it was "rapidly transferring manufacturing" across the Atlantic.
